The DNA Sequencing core is a new support laboratory that is jointly administered by the DRTC and the Vanderbilt-Ingram Cancer Center. This core will provide Center investigators with cost effective, rapid turnaround, high quality sequencing of a wide range of DNA templates using an existing state-of-the-art high throughput facility. DNA sequencing has become an integral and essential procedure for modern laboratories employing molecular biology and recombinant DNA technology. Many DRTC investigators depend heavily on centralized, quality controlled DNA sequencing for day-to-day operations. The Vanderbilt DNA Sequencing Facility operates two ABI 3700 automated DNA sequencers capable of analyzing up to 768 samples per day. The facility is also equipped with two robotic liquid handling workstations coupled with high capacity thermal cyclers for setting up and performing reactions with minimal hands-on intervention. Therefore, this core will provide Center investigators with access to an enormously powerful resource enabling their laboratories to execute molecular biology experiments with greater efficiency, reproducibility and for less cost. A charge-back mechanism will be employed to distribute the costs of DNA sequencing services proportionate to usage. The DNA Sequencing core is also expected to support work done in other DRTC core facilities including the Microarray arid Transgenic Cores.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Comprehensive Center (P60)
Project #
2P60DK020593-24
Application #
6660644
Study Section
Special Emphasis Panel (ZDK1)
Project Start
2002-07-20
Project End
2007-03-31
Budget Start
Budget End
Support Year
24
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37203
Bolus, W Reid; Peterson, Kristin R; Hubler, Merla J et al. (2018) Elevating adipose eosinophils in obese mice to physiologically normal levels does not rescue metabolic impairments. Mol Metab 8:86-95
West, Kathryn L; Kelm, Nathaniel D; Carson, Robert P et al. (2018) Myelin volume fraction imaging with MRI. Neuroimage 182:511-521
Barke, Theresa L; Goldstein, Jeffery A; Sundermann, Alexandra C et al. (2018) Gestational diabetes mellitus is associated with increased CD163 expression and iron storage in the placenta. Am J Reprod Immunol 80:e13020
Rohrbough, Jeffrey; Nguyen, Hong-Ngan; Lamb, Fred S (2018) Modulation of ClC-3 gating and proton/anion exchange by internal and external protons and the anion selectivity filter. J Physiol 596:4091-4119
Schlegel, Cameron; Lapierre, Lynne A; Weis, Victoria G et al. (2018) Reversible deficits in apical transporter trafficking associated with deficiency in diacylglycerol acyltransferase. Traffic 19:879-892
Moore, Mary Courtney; Smith, Marta S; Farmer, Ben et al. (2018) Morning Hyperinsulinemia Primes the Liver for Glucose Uptake and Glycogen Storage Later in the Day. Diabetes 67:1237-1245
Cooke, Allison L; Morris, Jamie; Melchior, John T et al. (2018) A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL. J Lipid Res 59:1244-1255
Moore, Mary Courtney; Kelley, David E; Camacho, Raul C et al. (2018) Superior Glycemic Control With a Glucose-Responsive Insulin Analog: Hepatic and Nonhepatic Impacts. Diabetes 67:1173-1181
Funkhouser-Jones, Lisa J; van Opstal, Edward J; Sharma, Ananya et al. (2018) The Maternal Effect Gene Wds Controls Wolbachia Titer in Nasonia. Curr Biol 28:1692-1702.e6
Hart, Nathaniel J; Aramandla, Radhika; Poffenberger, Gregory et al. (2018) Cystic fibrosis-related diabetes is caused by islet loss and inflammation. JCI Insight 3:

Showing the most recent 10 out of 1487 publications